The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for WerfenLife sales in Spain from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
WerfenLife SA (WerfenLife) formerly Werfen Life Group SA is a medical device company that develops and supplies in vitro diagnostic instruments and medical devices. The company provides in vitro diagnostics in the areas of autoimmune, haemostasis, critical care, hematology, clinical chemistry, immunology and serology, among others. It offers products in the areas of molecular biology, cytomics, bacteriology, urine analysis and flow citometry, among others. WerfenLife provides medical devices in areas of cardiovascular, diagnostic procedures, disposables, endovascular, gastroenterology, medical equipment and installations, orthopedics, surgical procedures and therapeutic procedures. The company also distributes instruments and consumables for use in research centers and industries. The company sells its products in Austria, Spain, Germany and Portugal. WerfenLife is headquartered in Barcelona, Spain. Key subsidiaries of WerfenLife include Immucor, Nicolai Medizintechnik, Werfen, Systelab Technologies and Accriva Diagnostics.
The key metrics of WerfenLife related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As WerfenLife is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as WerfenLife.
For a detailed understanding of the performance of WerfenLife, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
